Unlike other GHRPs that stimulate multiple hormone pathways, ipamorelin specifically targets growth hormone release without affecting cortisol, prolactin, or aldosterone levels
Miguel A, Snchez-Garrido, Sara JB, Christoffer C, Timo DM, Richard DD, et al
DOI: Published online: June 22, 2021 Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea Corresponding author: Bo Hyun Kim
For researchers designing Matrixyl vs GHK-Cu studies, the choice of endpoints profoundly affects protocol design
Appreciation to Nutrition Insight for the spotlight
Berberine, a plant alkaloid studied for blood sugar control, is increasingly combined with GLP-1 receptor agonists like semaglutide by patients seeking enhanced metabolic benefits